| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 10/22/2008 | EP1983055A1 Albumin fusion proteins |
| 10/22/2008 | EP1443945B1 Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis or chondromalacia |
| 10/16/2008 | WO2008123231A1 Novel cyclic staple-type oligonucleotide, and nf-κb decoy comprising the same |
| 10/16/2008 | US20080253987 Biomaterial from precursors pentaerythritol poly(ethylene glycol)ether tetra-sulfhydryl and an ethylene oxide-propylene oxide star polymer having ethylene diamine as the nucleus and acrylate end groups; containing biological fluids or gases; nonswelling, high mechanical strength, biocompatability |
| 10/15/2008 | EP1978975A1 Composition for inhibiting adhesion |
| 10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 10/15/2008 | EP1444202B1 Novel metalloproteinase inhibitors |
| 10/14/2008 | CA2384331C The use of halofuginone and related compounds for the treatment of urethral stricture by local administration |
| 10/14/2008 | CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery |
| 10/09/2008 | WO2008121328A2 Fluid composition for inhibiting surgical adhesion formation and related method of production |
| 10/09/2008 | WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation |
| 10/07/2008 | CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives |
| 10/02/2008 | US20080241270 Phosphite and a phenol antioxidant in an antistatic carrier of coconut fatty acid diethanolamine, diethanolamine and glycerin; euricamide, polyethylene resin, calcium carbonate; inhibit the development of post-surgery adhesions |
| 10/02/2008 | US20080241098 Antagonizing interleukin-21 receptor activity |
| 09/25/2008 | US20080233089 Modified Cells Expressing a Protein That Modulates Activity of Bhlh Proteins, and Uses Thereof |
| 09/24/2008 | CN100420446C Surgical flush fluid and its preparing process and application |
| 09/23/2008 | US7427619 Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/17/2008 | CN101264051A Modified release pharmaceutical formulation |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425549 Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 09/12/2008 | WO2008106724A1 Transplants |
| 09/12/2008 | CA2717162A1 Transplants |
| 09/11/2008 | US20080219983 Antihemophilic factor specific peptides for use as therapeutic tools in treatment of blood disorders |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/10/2008 | EP1965831A2 Use of c1 inhibitor for the prevention of ischemia-reperfusion injury |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | CN101259137A Instant matched medical styptic anti-adhesive flush fluid |
| 09/04/2008 | US20080213387 Isolated cytotrophoblast stem cell expresses HLA-G and HLA class I antigen; cytokeratin 7; stage specific embryonic antigen 1; human placental lactogen; caudal related homeobox; vimentin; Cd9 marker; chimeric cell for the modulation of cell/tissue rejection in transplantation therapy |
| 09/04/2008 | US20080213378 Atorvastatin; lovastatin; a keto analog of mevinolin; pravastatin; simvastatin; velostatin; fluindostatin; cetyl pyridinium, polymer, biopolymer surface stabilizers; suspensions, gels, aerosols, ointments, creams, controlled release; oral, pulmonary, rectal, opthalmic; improved pharmacokinetic profiles |
| 09/03/2008 | CN100415245C Post-surgery anti-accretion material capable of gelatinized in situ or by injection and preparation process thereof |
| 09/02/2008 | CA2395037C The use of scopolamine salts |
| 08/28/2008 | US20080207746 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis; using halogenated xanthene compound |
| 08/28/2008 | US20080207584 Compound Having S1P Receptor Binding Potency and Use Thereof |
| 08/28/2008 | US20080206207 Intracoronary Device And Method Of Use Thereof |
| 08/21/2008 | WO2008098364A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/21/2008 | US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
| 08/21/2008 | US20080200421 Heparin linked to bioabsorbable polylactone; restenosis prevention; stent implants; synthesis |
| 08/21/2008 | CA2675793A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7414038 embolizing agent for arteriovenous aneurysm, which comprises the embolizing material and an appropriate physiologically acceptable water-soluble organic acid |
| 08/14/2008 | WO2008096722A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/14/2008 | CA2677657A1 Agent for preventing bleeding from cerebral cortical vein |
| 08/07/2008 | US20080187571 mixture of calcium phosphate, collagen and glass; reabsorption |
| 08/06/2008 | CN100408567C Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 07/29/2008 | CA2461921C Composition of hypochlorous acid and its applications |
| 07/29/2008 | CA2449947C Antiadhesive material |
| 07/24/2008 | WO2008088030A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 07/24/2008 | WO2007146841A3 Collagen cross-linking agents on dental restorative treatment and preventive dentistry |
| 07/24/2008 | CA2675836A1 Composition for preventing or treating thrombus- or embolus-associated disease |
| 07/22/2008 | US7402601 ADMINISTERING A DRUG CONTAINING N-(4-TRIFLUOROMETHYLphenyl)-5-METHYLISOXAZOLE-4-CARBOXANILIDE or N-(4-TRIFLUOROMETHYLPHENYL)-2-CYANO-3-HYDROXYCROTONAMIDE; antiinflammatory agents, immunomodulators, immunosuppressants |
| 07/17/2008 | WO2008057590A3 Methods and compositions for modulating tissue modeling |
| 07/17/2008 | US20080171792 Administering aqueous sodium 4-phenylbutyrate to treat spinal muscular atrophy, central nervous system cancer, myelodysplastic syndrome, acute leukemia, glioblastoma multiforme, amyotrophic lateral sclerosis and colon cancer; cherry flavored liquid for children |
| 07/16/2008 | CN100402025C Modified release pharmaceutical formulation |
| 07/10/2008 | WO2008083226A2 Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| 07/10/2008 | WO2008080336A1 Use of high osmotic liquid composition in manufacturing medicament for enhancing wound healing |
| 07/10/2008 | US20080167630 Controlled delivery system |
| 07/10/2008 | US20080167609 Methods of treating vascular disease |
| 07/10/2008 | US20080167388 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 07/10/2008 | US20080167220 Methods for selectively inhibiting janus tyrosine kinase 3 (jak3) |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | CA2339384C Improved method for targeted topical treatment of disease |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 06/26/2008 | US20080153882 Pharmaceutical Composition Comprising Ppar Regulator |
| 06/26/2008 | US20080152690 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 06/26/2008 | US20080152656 Using kallikren specific inhibitor as therapeutic tool in treating cardiocascular disorders; treating soft tissue and bone trauma; tissue repair |
| 06/19/2008 | US20080147045 Use of VEGF-C or VEGF-D in Reconstructive Surgery |
| 06/19/2008 | US20080146673 Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same |
| 06/19/2008 | US20080145359 Imaging, diagnosis and treatment of disease |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/12/2008 | US20080140192 Reversible thermoresponsive adhesives for implants |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN100393323C Methods of treating vascular disease |
| 06/10/2008 | US7385052 Preparing preefrentially linked chemical intermediates; obtain hyaluronic acid, incubate with glutaraldehyde, recover reaction product |
| 06/10/2008 | CA2361981C Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/05/2008 | US20080131473 Cell-Independent Fabrication of Tissue Equivalents |
| 06/05/2008 | US20080131426 Using kallikren specific immunoglobulin as therapeutic tool in treating cardiocascular disorders; tissue repair |
| 06/05/2008 | US20080131399 Using interferon alpha chimera to treat and prevent cell proliferative and viral diseases |
| 06/04/2008 | CN101193645A Liquid for preventing tissue adhesion and method of preventing tissue adhesion |
| 06/04/2008 | CN100391933C Substituted 1-aminobutan-3-01 derivatives |
| 05/29/2008 | US20080125376 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | US20080119494 Drug-enhanced adhesion prevention |
| 05/21/2008 | EP1531791A4 Prevention and reduction of blood loss |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/14/2008 | EP1021148B1 Composition and method for acceleration of wound and burn healing |
| 05/14/2008 | CN100387238C Medical hemostasis anti-adhesive irrigation solution |
| 05/13/2008 | CA2344222C Adhesive protein foam for surgical and/or therapeutic uses |
| 05/13/2008 | CA2279939C Treatment and prevention of adhesions |
| 05/13/2008 | CA2206119C Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 05/08/2008 | US20080108706 dosage forms contains N1,N14-Diethyl-3(R) 12(R)-dihydroxyhomospermine for TREATMENT OF PANCREATIC CANCER |
| 05/08/2008 | US20080107689 Stable Microbial Inoculants and Methods for Production of Them |
| 05/07/2008 | CN100386090C Medical dust cloud agent or granular agent and its use |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/01/2008 | US20080102064 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 05/01/2008 | US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction |